These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Bischof D; Pulford K; Mason DY; Morris SW Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481 [TBL] [Abstract][Full Text] [Related]
4. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Pulford K; Lamant L; Morris SW; Butler LH; Wood KM; Stroud D; Delsol G; Mason DY Blood; 1997 Feb; 89(4):1394-404. PubMed ID: 9028963 [TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target. Werner MT; Zhao C; Zhang Q; Wasik MA Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258 [TBL] [Abstract][Full Text] [Related]
6. Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R J Biol Chem; 2010 Aug; 285(34):26441-50. PubMed ID: 20554525 [TBL] [Abstract][Full Text] [Related]
7. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Ceccon M; Merlo MEB; Mologni L; Poggio T; Varesio LM; Menotti M; Bombelli S; Rigolio R; Manazza AD; Di Giacomo F; Ambrogio C; Giudici G; Casati C; Mastini C; Compagno M; Turner SD; Gambacorti-Passerini C; Chiarle R; Voena C Oncogene; 2016 Jul; 35(29):3854-3865. PubMed ID: 26657151 [TBL] [Abstract][Full Text] [Related]
8. [Nucleophosmin mutations in hematological malignancies - review]. Luo ZP; Zhang L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933 [TBL] [Abstract][Full Text] [Related]
14. The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions. Hegazy SA; Wang P; Anand M; Ingham RJ; Gelebart P; Lai R J Biol Chem; 2010 Jun; 285(26):19813-20. PubMed ID: 20424160 [TBL] [Abstract][Full Text] [Related]
15. EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53. Uchihara Y; Tago K; Tamura H; Funakoshi-Tago M Mol Oncol; 2021 Jan; 15(1):167-194. PubMed ID: 33040459 [TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis. Konoplev S; Huang X; Drabkin HA; Koeppen H; Jones D; Kantarjian HM; Garcia-Manero G; Chen W; Medeiros LJ; Bueso-Ramos CE Cancer; 2009 Oct; 115(20):4737-44. PubMed ID: 19637342 [TBL] [Abstract][Full Text] [Related]
18. Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: a pilot study. Kassem N; Hamid AA; Attia T; Baathallah S; Mahmoud S; Moemen E; Safwat E; Khalaf M; Shaker O J Egypt Natl Canc Inst; 2011 Jun; 23(2):73-8. PubMed ID: 22099964 [TBL] [Abstract][Full Text] [Related]
19. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999 [TBL] [Abstract][Full Text] [Related]
20. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Cussac D; Greenland C; Roche S; Bai RY; Duyster J; Morris SW; Delsol G; Allouche M; Payrastre B Blood; 2004 Feb; 103(4):1464-71. PubMed ID: 14563642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]